Your browser doesn't support javascript.
loading
Gene-silencing suppressors for high-level production of the HIV-1 entry inhibitor griffithsin in Nicotiana benthamiana.
Habibi, Peyman; Soccol, Carlos Ricardo; O'Keefe, Barry R; Krumpe, Lauren R H; Wilson, Jennifer; de Macedo, Leonardo Lima Pepino; Faheem, Muhammad; Dos Santos, Vanessa Olinto; Prado, Guilherme Souza; Botelho, Marco Antonio; Lacombe, Severine; Grossi-de-Sa, Maria Fatima.
Afiliación
  • Habibi P; Department of Bioprocess Engineering and Biotechnology, Federal University of Paraná, Curitiba, PR, Brazil.
  • Soccol CR; Embrapa Genetic Resources and Biotechnology, PqEB-Final W5 Norte - CP 02372, Brasília-DF, Brazil.
  • O'Keefe BR; Department of Bioprocess Engineering and Biotechnology, Federal University of Paraná, Curitiba, PR, Brazil.
  • Krumpe LRH; Molecular Targets Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA.
  • Wilson J; Natural Products Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD, USA.
  • de Macedo LLP; Basic Science Program, Leidos Biomedical Research, Inc., Molecular Targets Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Faheem M; Molecular Targets Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA.
  • Dos Santos VO; Embrapa Genetic Resources and Biotechnology, PqEB-Final W5 Norte - CP 02372, Brasília-DF, Brazil.
  • Prado GS; Embrapa Genetic Resources and Biotechnology, PqEB-Final W5 Norte - CP 02372, Brasília-DF, Brazil.
  • Botelho MA; Embrapa Genetic Resources and Biotechnology, PqEB-Final W5 Norte - CP 02372, Brasília-DF, Brazil.
  • Lacombe S; Embrapa Genetic Resources and Biotechnology, PqEB-Final W5 Norte - CP 02372, Brasília-DF, Brazil.
  • Grossi-de-Sa MF; Post Graduation Program in Biotechnology, University Potiguar, Natal, RN, Brazil.
Process Biochem ; 70: 45-54, 2018 Jul.
Article en En | MEDLINE | ID: mdl-32288594
ABSTRACT
The exploration of emerging host organisms for the economic and efficient production of protein microbicides against HIV is urgently needed in resource-poor areas worldwide. In this study, the production of the novel HIV entry inhibitor candidate, griffithsin (GRFT), was investigated using Nicotiana benthamiana as the expression platform based on a non-viral vector. To increase the yield of recombinant GRFT, the RNA silencing defense mechanism of N. benthamiana was abolished by using three gene silencing suppressors. A transient expression system was used by transferring the GRFT gene, which encodes 122 amino acids, under the control of the enhanced CaMV 35S promoter. The presence of correctly assembled GRFT in transgenic leaves was confirmed using immunoglobulin-specific sandwich ELISA. The data demonstrated that the use of three gene silencing suppressors allowed the highest accumulation of GRFT, with a yield of 400 µg g-1 fresh weight, and this amount was reduced to 287 µg g-1 after purification, representing a recovery of 71.75%. The analysis also showed that the ability of GRFT expressed in N. benthamiana to bind to glycoprotein 120 is close to that of the GRFT protein purified from E. coli. Whole-cell assays using purified GRFT showed that our purified GRFT was potently active against HIV. This study provides the first high-level production of the HIV-1 entry inhibitor griffithsin with a non-viral expression system and illustrates the robustness of the co-agroinfiltration expression system improved through the use of three gene silencing suppressors.
Palabras clave